C. Anders Olson

This paper develops AFMT analogs that inhibit gut bacterial L-dopa decarboxylases while reducing susceptibility to host metabolism.

The paper shows that a bacterial operon in the gut microbiome can reduce drug toxicity during cancer treatment by inactivating 5-fluorouracil.

This study shows that early life sugar consumption alters gut microbiota and impairs hippocampal-dependent memory in rats, with specific bacterial taxa linked to these effects.

This study shows that gut microbiota differences between mouse strains contribute to varied metabolic responses to high fructose consumption, with Akkermansia playing a key protective role.